Project Definition

New products are to be developed for EMEA markets. They are intended to be marketed as D2C products, i.e. direct to consumers. They should be accepted by medical practitioners for advocating to their patients. Therefore products offered must be well documented to be capable of improving cardiovascular health or reducing risks factors. Solutions for this can be by supplementing particular nutrients, providing specific bioactive substances, provide concrete personal data on life style and individual heart health related biomarkers, or to provide remedies or tools directly assisting in life style modification.

Actions

• Mapping potential solutions according to risk factors and conceptsClients channel options
• Screening macro market in geographical scopes
• Screening recent product lauches
• Screening health area ingredients
• Bench marking and ranking ingredients

Reporting and summarizing in a workshop